 |
MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 /PRNewswire/ — Telix Prescribed drugs Restricted (ASX: TLX, NASDAQ: TLX, “Telix”) at this time declares an academic webinar exploring the unmet wants in neurologic oncology (particularly glioma and glioblastoma) and the way theranostics might assist tackle these.
David N. Cade, MD, Telix Group Chief Medical Officer will present a medical replace, which can be adopted by a hearth chat with Nelleke Tolboom, MD, Nuclear Drugs doctor and tutorial school member at UMC Utrecht (Netherlands) and Josef Pichler, MD, Head of the Neuro-oncological Middle at Kepler College Hospital Linz (Austria).
The presentation can be adopted by Q&A with Dr. Cade and Richard Valeix, CEO, Telix Therapeutics.
Webinar date and time:
EDT: Monday, June 29, 2026, 5:00 p.m.
AEST: Tuesday, June 30, 2026, 7:00 a.m.
Contributors can register for the webinar on the following hyperlink:
https://s1.c-conf.com/diamondpass/10054826-mur5i9.html
About Telix Prescribed drugs Restricted
Telix is a world biopharmaceutical firm targeted on the event and commercialization of radiopharmaceuticals with the objective of addressing important unmet medical want in oncology and uncommon ailments. Telix is headquartered in Melbourne (Australia) with worldwide operations in the USA, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland) and Japan. Telix is listed on the Australian Securities Alternate (ASX: TLX) and the Nasdaq World Choose Market (NASDAQ: TLX).
Go to www.telixpharma.com for additional details about Telix, together with particulars of the most recent share worth, ASX and U.S. Securities and Alternate Fee (SEC) filings, investor and analyst shows, information releases, occasion particulars and different publications that could be of curiosity. It’s also possible to comply with Telix on LinkedIn, X and Fb.
Authorized Notices
Cautionary Assertion Concerning Ahead-Wanting Statements.
It is best to learn this announcement along with our danger components, as disclosed in our most just lately filed reviews with the Australian Securities Alternate (ASX), U.S. Securities and Alternate Fee (SEC), together with our Annual Report on Kind 20-F filed with the SEC, or on our web site.
The data contained on this announcement just isn’t supposed to be a proposal for subscription, invitation or suggestion with respect to securities of Telix Prescribed drugs Restricted (Telix) in any jurisdiction, together with the USA. The data and opinions contained on this announcement are topic to alter with out notification. To the utmost extent permitted by regulation, Telix disclaims any obligation or enterprise to replace or revise any data or opinions contained on this announcement, together with any forward-looking statements (as referred to under), whether or not on account of new data, future developments, a change in expectations or assumptions, or in any other case. No illustration or guarantee, specific or implied, is made in relation to the accuracy or completeness of the knowledge contained or opinions expressed in the midst of this announcement.
This announcement might include forward-looking statements, together with inside the which means of the U.S. Non-public Securities Litigation Reform Act of 1995, that relate to anticipated future occasions, monetary efficiency, plans, methods or enterprise developments. Ahead-looking statements can typically be recognized by means of phrases equivalent to “might”, “count on”, “intend”, “plan”, “estimate”, “anticipate”, “imagine”, “outlook”, “forecast” and “steerage”, or the damaging of those phrases or different comparable phrases or expressions. Ahead-looking statements contain recognized and unknown dangers, uncertainties and different components which will trigger our precise outcomes, ranges of exercise, efficiency or achievements to vary materially from any future outcomes, ranges of exercise, efficiency or achievements expressed or implied by these forward-looking statements. Ahead-looking statements are primarily based on Telix’s good-faith assumptions as to the monetary, market, regulatory and different dangers and concerns that exist and have an effect on Telix’s enterprise and operations sooner or later and there may be no assurance that any of the assumptions will show to be appropriate. Within the context of Telix’s enterprise, forward-looking statements might embody, however usually are not restricted to, statements about: the initiation, timing, progress, completion and outcomes of Telix’s preclinical and medical trials, and Telix’s analysis and improvement packages; Telix’s capability to advance product candidates into, enroll and efficiently full, medical research, together with multi-national medical trials; the timing or chance of regulatory filings and approvals for Telix’s product candidates, manufacturing actions and product advertising actions; Telix’s gross sales, advertising and distribution and manufacturing capabilities and methods; the commercialization of Telix’s product candidates, if or once they have been accepted; Telix’s capability to acquire an ample provide of uncooked supplies at affordable prices for its merchandise and product candidates; estimates of Telix’s bills, future revenues and capital necessities; Telix’s monetary efficiency; developments regarding Telix’s rivals and trade; the anticipated affect of U.S. and international tariffs and different macroeconomic situations on Telix’s enterprise, together with on account of struggle or different geopolitical conflicts; and the pricing and reimbursement of Telix’s product candidates, if and after they’ve been accepted. Telix’s precise outcomes, efficiency or achievements could also be materially totally different from these which can be expressed or implied by such statements, and the variations could also be antagonistic. Accordingly, you shouldn’t place undue reliance on these forward-looking statements.
Logos and Commerce Names. All emblems and commerce names referenced on this press launch are the property of Telix Prescribed drugs Restricted (Telix) or, the place relevant, the property of their respective house owners. For comfort, emblems and commerce names might seem with out the ® or ™ symbols. Such omissions usually are not supposed to point any waiver of rights by Telix or the respective house owners. Trademark registration standing might differ from nation to nation. Telix doesn’t intend the use or show of any third-party emblems or commerce names to suggest any affiliation with, endorsement by, or sponsorship from these third events.
©2026 Telix Prescribed drugs Restricted. All rights reserved.
